The metabolic syndrome - A new worldwide definition

Lancet

Volumn 366, Issue 9491, 2005, Pages 1059-1062

  Alberti, K George M M ^a   Zimmet, Paul ^b   Shaw, Jonathan ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; EDUCATION PROGRAM; ETHNOLOGY; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; METABOLIC SYNDROME X; NOTE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR;

ASIA, SOUTHEASTERN; CARDIOVASCULAR DISEASES; CHINA; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 25144459980     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67402-8     Document Type: Note

References (21)

1. RH Eckel, SM Grundy, PZ Zimmet The metabolic syndrome Lancet 365 2005 1415 1428
2. E Kylin Studien ueber das Hypertonie-Hyperglyka "mie- Hyperurika" miesyndrom Zentralblatt fuer Innere Medizin 44 1923 105 127
3. G Reaven Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
4. I Lemieux, A Pascot, C Couillard Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102 2000 179 184
5. K Alberti, P Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
6. B Balkau, MA Charles Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med 16 1999 442 443
7. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
8. AJ Cameron, JE Shaw, PZ Zimmet The metabolic syndrome: prevalence in worldwide populations Endocrinol Metab Clin North Am 33 2004 351 376
9. MP Stern, K Williams, C Gonzalez-Villalpando, KJ Hunt, SM Haffner Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27 2004 2676 2681
10. HM Lakka, DE Laaksonen, TA Lakka The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
11. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 2004 157 163
12. CE Tan, S Ma, D Wai, SK Chew, ES Tai Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27 2004 1182 1186
13. International Diabetes Federation The IDF consensus worldwide definition of the metabolic syndrome http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf April 14, 2005 (accessed June 10, 2005).
14. Snehalatha C, Viswanathan V, Ramachandran A Cutoff values for normal anthropometric variables in asian Indian adults Diabetes Care 26 2003 1380 1384
15. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity New criteria for 'obesity disease' in Japan Circ J 66 2002 987 992
16. S Genuth, KG Alberti, P Bennett Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
17. J Lindstrom, A Louheranta, M Mannelin, for the Finnish Diabetes Prevention Study Group The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity Diabetes Care 26 2003 3230 3236
18. LF Van Gaal, AM Rissanen, AJ Scheen, the RIO-Europe Study Group Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study Lancet 365 2005 1389 1397
19. R Kahn, J Buse, E Ferrannini, M Stern The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 28 2005 2289 2304 [Also Diabetologia 2005; published online Aug 4. DOI:10.1007/s00125-005- 1876-2]
20. P Zimmet, J Shaw, KG Alberti Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view Diabet Med 20 2003 693 702
21. EAM Gale Editorial: the myth of the metabolic syndrome Diabetologia 10 2005 1873 1875